When the American Cancer Society announced new guidelines for mammograms a week ago, the response on the organization’s Facebook page was swift. “For adoptees, this just adds 5 more years of potential unknowing,” wrote Angela from Connecticut. “Without a medical history, we are denied mammograms through insurance carriers.”
And then Dr. Henry Jacobs, a Hartford area longtime OB-GYN who, among other duties, serves as the Connecticut State Medical Society president, took to Facebook, too, and posted a message that summarized the general rage: “It is clear that rationing care is the new sales pitch and sacrificing women that could live out their lives is considered acceptable. I think it is UNCONSCIONABLE!!!!!!! We can afford athletes, entertainers, CEOs, hedge fund scammers that make upwards of a 100 million $$$$$ a year, but we can’t provide decent medical care to people???
Medicare-funded breast cancer screenings jumped 44 percent from $666 million to $962 million from 2001 to 2009, yet those added costs did not improve early detection rates among the 65 and older Medicare population, according to a Yale School of Medicine study published recently in the Journal of the National Cancer Institute. The increase was due mostly to the use of costlier digital mammography ($115 per screening) compared to film mammography ($73 per screening), along with newer and expensive screening and adjunct technologies, including breast ultrasound, magnetic resonance imaging (MRI) and biopsy. The study is the second from Yale since January 2013 to conclude that increased Medicare spending for breast cancer screening does not necessarily translate into better outcomes. The latest study has spurred debate about the cost and value of mammography in Medicare beneficiaries, particularly women 75 and older. Some physicians recommend continued screening, while others argue that it is unnecessary and only fuels anxiety among older women.